113 related articles for article (PubMed ID: 11162500)
1. Dissociation of DNA binding and in vitro transcriptional activities dependent on the C terminus of P53 proteins.
Kaku S; Albor A; Kulesz-Martin M
Biochem Biophys Res Commun; 2001 Jan; 280(1):204-11. PubMed ID: 11162500
[TBL] [Abstract][Full Text] [Related]
2. Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potential.
Mundt M; Hupp T; Fritsche M; Merkle C; Hansen S; Lane D; Groner B
Oncogene; 1997 Jul; 15(2):237-44. PubMed ID: 9244359
[TBL] [Abstract][Full Text] [Related]
3. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
[TBL] [Abstract][Full Text] [Related]
4. Microinjection of monoclonal antibody PAb421 into human SW480 colorectal carcinoma cells restores the transcription activation function to mutant p53.
Abarzúa P; LoSardo JE; Gubler ML; Neri A
Cancer Res; 1995 Aug; 55(16):3490-4. PubMed ID: 7627952
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 physically associates with p53 and stimulates its transcriptional activity.
Zhang H; Somasundaram K; Peng Y; Tian H; Zhang H; Bi D; Weber BL; El-Deiry WS
Oncogene; 1998 Apr; 16(13):1713-21. PubMed ID: 9582019
[TBL] [Abstract][Full Text] [Related]
6. The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability.
Hansen S; Lane DP; Midgley CA
J Mol Biol; 1998 Jan; 275(4):575-88. PubMed ID: 9466932
[TBL] [Abstract][Full Text] [Related]
7. YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription.
Yakovleva T; Kolesnikova L; Vukojević V; Gileva I; Tan-No K; Austen M; Lüscher B; Ekström TJ; Terenius L; Bakalkin G
Biochem Biophys Res Commun; 2004 May; 318(2):615-24. PubMed ID: 15120643
[TBL] [Abstract][Full Text] [Related]
8. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro.
Hainaut P; Milner J
Cancer Res; 1993 Oct; 53(19):4469-73. PubMed ID: 8402615
[TBL] [Abstract][Full Text] [Related]
9. Inactive p53 mutants may enhance the transcriptional activity of wild-type p53.
Zhang W; Shay JW; Deisseroth A
Cancer Res; 1993 Oct; 53(20):4772-5. PubMed ID: 8402659
[TBL] [Abstract][Full Text] [Related]
10. On the mechanism of sequence-specific DNA-dependent acetylation of p53: the acetylation motif is exposed upon DNA binding.
Cesková P; Chichger H; Wallace M; Vojtesek B; Hupp TR
J Mol Biol; 2006 Mar; 357(2):442-56. PubMed ID: 16438982
[TBL] [Abstract][Full Text] [Related]
11. Specific modulation of p53 binding to consensus sequence within supercoiled DNA by monoclonal antibodies.
Brázda V; Paleĉek J; Pospísilová S; Vojtêsek B; Paleĉek E
Biochem Biophys Res Commun; 2000 Jan; 267(3):934-9. PubMed ID: 10673394
[TBL] [Abstract][Full Text] [Related]
12. Novel DNA binding of p53 mutants and their role in transcriptional activation.
Zhang W; Funk WD; Wright WE; Shay JW; Deisseroth AB
Oncogene; 1993 Sep; 8(9):2555-9. PubMed ID: 8361764
[TBL] [Abstract][Full Text] [Related]
13. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
14. Binding sequence-dependent regulation of the human proliferating cell nuclear antigen promoter by p53.
Shan B; Morris GF
Exp Cell Res; 2005 Apr; 305(1):10-22. PubMed ID: 15777783
[TBL] [Abstract][Full Text] [Related]
15. Tumour associated mutants of p53 can inhibit transcriptional activity of p53 without heterooligomerization.
Jõers A; Kristjuhan A; Kadaja L; Maimets T
Oncogene; 1998 Nov; 17(18):2351-8. PubMed ID: 9811466
[TBL] [Abstract][Full Text] [Related]
16. Binding to the naturally occurring double p53 binding site of the Mdm2 promoter alleviates the requirement for p53 C-terminal activation.
Kaku S; Iwahashi Y; Kuraishi A; Albor A; Yamagishi T; Nakaike S; Kulesz-Martin M
Nucleic Acids Res; 2001 May; 29(9):1989-93. PubMed ID: 11328884
[TBL] [Abstract][Full Text] [Related]
17. The requirement of the carboxyl terminus of p53 for DNA binding and transcriptional activation depends on the specific p53 binding DNA element.
Zhang W; Guo XY; Deisseroth AB
Oncogene; 1994 Sep; 9(9):2513-21. PubMed ID: 8058314
[TBL] [Abstract][Full Text] [Related]
18. Specific DNA binding by different classes of human p53 mutants.
Rolley N; Butcher S; Milner J
Oncogene; 1995 Aug; 11(4):763-70. PubMed ID: 7651740
[TBL] [Abstract][Full Text] [Related]
19. p53 protein is activated during muscle differentiation and participates with MyoD in the transcription of muscle creatine kinase gene.
Tamir Y; Bengal E
Oncogene; 1998 Jul; 17(3):347-56. PubMed ID: 9690516
[TBL] [Abstract][Full Text] [Related]
20. Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay.
Di Como CJ; Prives C
Oncogene; 1998 May; 16(19):2527-39. PubMed ID: 9627118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
